The effect of microbiota-based investigational drug RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial

MLA

Margaret H. Bost, et al. The Effect of Microbiota-Based Investigational Drug RBX2660 on the Gut Microbiome and Resistome Revealed by a Placebo-Controlled Clinical Trial. Mar. 2020. EBSCOhost, https://doi.org/10.21203/rs.3.rs-17152/v1.

APA

Margaret H. Bost, Gautam Dantas, Kenneth Blount, Tiffany Hink, Kimberly A. Reske, JooHee Choi, Suryang Kwak, Courtney Jones, Erik R. Dubberke, Carey-Ann D. Burnham, & Xiaoqing Sun. (2020). The effect of microbiota-based investigational drug RBX2660 on the gut microbiome and resistome revealed by a placebo-controlled clinical trial. https://doi.org/10.21203/rs.3.rs-17152/v1

Chicago

Margaret H. Bost, Gautam Dantas, Kenneth Blount, Tiffany Hink, Kimberly A. Reske, JooHee Choi, Suryang Kwak, et al. 2020. “The Effect of Microbiota-Based Investigational Drug RBX2660 on the Gut Microbiome and Resistome Revealed by a Placebo-Controlled Clinical Trial,” March. doi:10.21203/rs.3.rs-17152/v1.